Adrienne Lindblad

Jun 17, 2024 | cfp.ca | Michael R Kolber |Adrienne Lindblad |Scott W. Klarenbach |G. Michael Allan

We thank Dr Aubrey-Bassler for his comment1 pertaining to the PEER simplified lipid guideline 2023 update.2 Both the 2023 and 2015 PEER simplified lipid guidelines do not recommend repeat lipid testing for primary or secondary prevention patients, or treating to a target low-density lipoprotein level after initiation of statins.2,3 In our guideline we state, “In secondary prevention, if additional cardiovascular risk reduction is desired beyond maximized statin therapy, we recommend a...

Mar 18, 2024 | cfp.ca | Jennifer Young |Erin Lee |Adrienne Lindblad |Jamie Falk

Clinical questionAre orexin antagonists safe and effective for treatment of primary insomnia? Bottom lineOrexin antagonists help people fall asleep about 9 minutes faster and increase total sleep time by about 19 minutes versus placebo over the course of 1 to 3 months. About 8% of those taking orexin antagonists will experience next-day somnolence compared with 2% taking placebo. EvidenceSeven systematic reviews of RCTs were found1-7; we report mainly on the most recent and comprehensive review.

May 12, 2023 | cfp.ca | Danielle Perry |Samantha Moe |Betsy Thomas |Adrienne Lindblad

Review ArticleClinical Review From the PEER team Canadian Family Physician 69 (5) 325-329; DOI: https://doi.org/10.46747/cfp.6905325 AbstractObjective To summarize 10 high-quality medical articles published in 2022 that are relevant to primary care physicians.